Lv1
100 积分 2022-11-10 加入
Long-Term Efficacy and Safety of Stapokibart in Adults with Moderate-to-Severe Atopic Dermatitis: An Open-Label Extension, Nonrandomized Clinical Trial
5天前
已完结
Tofacitinib and Risk of Malignancy: Results From the Safety of Tofacitinib in Routine Care Patients With Rheumatoid Arthritis (STAR‐RA) Study
24天前
已完结
JAK inhibitor reinvigorates cancer immunotherapy
24天前
已完结
Long-Term Efficacy and Safety of Stapokibart in Adults with Moderate-to-Severe Atopic Dermatitis: An Open-Label Extension, Nonrandomized Clinical Trial
26天前
已完结
Long‐term efficacy and safety of stapokibart for moderate‐to‐severe atopic dermatitis: 52‐week results from a phase 3 trial
26天前
已完结
JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
2个月前
已完结
Alopecia Areata
2个月前
已完结
Study of preventive treatment with combined theray in tuberulosis Children
2个月前
已完结
Inhibiting Janus kinases to treat alopecia areata
3个月前
已完结
Janus kinase inhibitors for alopecia areata
3个月前
已完结
皖公网安备34019202002308
